• About BreezyScroll
  • Privacy & Policy
  • Contact Us
Tuesday, July 21, 2026
BreezyScroll
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer
No Result
View All Result
BreezyScroll
No Result
View All Result

Home  /  Science  /  UK: Experimental gene therapy cures incurable cancer in teen

UK: Experimental gene therapy cures incurable cancer in teen

by KS Arpitha
December 14, 2022
in Health, Science
Reading Time: 2 mins read
Experimental gene therapy cures incurable cancer in teen

CAR-T, an experimental gene therapy cured a previously “incurable” leukemia in a teenager. Read to know more about the procedure and the miraculous recovery.

What is CAR-T?

Thanks to an experimental gene therapy paving the way with new genetic immunotherapy, 13-year-old Alyssa from Leicester, UK is free of “previously incurable” leukemia. The teenager was suffering from T-cell lymphoblastic leukemia, a condition affecting T-lymphocytes, a type of immune white blood cell created in the bone marrow. It is fast-moving cancer where cells divide and enter the bloodstream before traveling to the spleen, liver, and lymph nodes. The condition can lead to death in a span of months. While procedures such as bone marrow transplant and chemotherapy exist, they are difficult and were unsuccessful in Alyssa’s case.

Hence, doctors approved an experimental CRISPR-based therapy. The Chimerica Antigen Receptors Cell Therapy (CAR-T) is a new individualized method that uses T-cell samples for reprogramming the DNA base to fight cancer. Since each cancer is different, CAR-T therapy varies from patient to patient. It is different from typical gene editing and targets each base and changes them. 

More on the experimental gene therapy

The CAR-T performs modification of T-cells to ensure they do not attack the patient’s cells and lead to autoimmune conditions. It also involves removing CD7, a cell marker, and then protecting the cells from chemotherapy. The new T-cells in the patient target any cell presenting the cell marker. While it is delicate, it has very few errors and ensures minimal or no complications.

“Since Alyssa got sick with her leukemia in May last year, she never achieved complete remission. Not with chemotherapy and not after her first bone marrow transplant,” stated Dr, Robert Chiesa. Dr. Chiesa is a consultant in CAR-T cell therapy and Bone Marrow Transplant.

“This is quite remarkable, although it is still a preliminary result, which needs to be monitored and confirmed over the next few months. We have been very impressed by how brave she is and nothing makes me happier than seeing her outside the hospital, going back to a more normal type of life,” he added.

Tags: Experimental gene therapy
ShareTweetShareSend

Recent Articles

Andy Burnham Becomes UK Prime Minister After Keir Starmer’s Resignation: How Britain’s Leadership Changed Without an Election

Andy Burnham Becomes UK Prime Minister After Keir Starmer’s Resignation: How Britain’s Leadership Changed Without an Election

July 20, 2026
Google Delays Gemini 3.5 Pro Again: Reports Point to Coding Challenges Behind the Hold-Up

Google Delays Gemini 3.5 Pro Again: Reports Point to Coding Challenges Behind the Hold-Up

July 20, 2026
Apple vs OpenAI Lawsuit: Everything Apple Alleges Was Stolen in the High-Stakes Trade Secrets Case

Apple vs OpenAI Lawsuit: Everything Apple Alleges Was Stolen in the High-Stakes Trade Secrets Case

July 20, 2026
FIFA Opens Investigation After Argentina-Spain World Cup Final Brawl, Players Could Face Sanctions

FIFA Opens Investigation After Argentina-Spain World Cup Final Brawl, Players Could Face Sanctions

July 20, 2026
BreezyScroll Logo

BreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.

Follow Us

Browse by Category

  • Africa
  • Alaska
  • Animals
  • Asia
  • Athletics
  • Australia
  • Auto
  • Basketball
  • Bollywood
  • Brand
  • Breezy Explainer
  • Breezy Feature
  • Breezy Soul
  • Business
  • Canada
  • Chess
  • China
  • Coronavirus
  • Cricket
  • DIY
  • Education
  • Entertainment
  • Environment
  • EPL
  • Europe
  • Exclusive Interview
  • Exclusive Review
  • Football
  • Gaming
  • Health
  • Hollywood
  • India
  • International
  • K Pop
  • Law
  • Lifestyle
  • Middle East
  • Money
  • NFL
  • North America
  • OTT
  • Paris Olympics
  • Pets
  • Press Releases
  • Russia
  • Science
  • South America
  • Space
  • Sports
  • Startup
  • Technology
  • Tennis
  • Tennis
  • The Achievers
  • The US
  • Travel
  • UK
  • UK
  • Uncategorized
  • World
  • WWE

Trending Topics

AI Apple Australia Biden California Canada ChatGPT China Climate Change Coronavirus COVID-19 Donald Trump Elon Musk Featured Florida Google IPL Iran Japan Joe Biden Mars Meta Moon NASA NBA Netflix New York North Korea Ohio OpenAI Putin Russia Russia-Ukraine crisis South Korea Taliban Tesla Texas TikTok Trump Twitter UFO UK Ukraine USA Virat Kohli

No Result
View All Result
  • About BreezyScroll
  • Privacy & Policy
  • Contact Us

© 2024 · BreezyScroll.com

No Result
View All Result
  • Home
  • Breezy Stories
  • Technology
  • Gaming
  • Entertainment
  • Lifestyle
  • World
  • Money
  • Sports
  • Breezy Explainer

© 2024 · BreezyScroll.com

Go to mobile version